Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Mendel currently holds 12,527 shares of GenMark Diagnostics, Inc. (GNMK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Mendel has been a net seller of GNMK stock. They have purchased $423.8K and sold $5.9M worth of shares.
Scott Mendel's most recent insider trade was on Apr 1, 2026, when they sold 4,310 shares at $0.00 per share.
Scott Mendel serves as Executive at GenMark Diagnostics, Inc. (GNMK). They have executed 112 insider transactions totaling $6.3M over their tenure at the company.
Scott Mendel holds the position of Executive at GenMark Diagnostics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Scott Mendel has shown a selling trading pattern, with $423.8K in total purchases and $5.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Scott Mendel was on Apr 22, 2021, when they sold $12.2M worth of GNMK shares. This transaction involved 507,198 shares at $24.05 per share.
Scott Mendel currently owns 12,527 shares of GenMark Diagnostics, Inc. (GNMK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Mendel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Mendel has 112 Form 4 filings on record as an insider at GenMark Diagnostics, Inc..
Set alerts for Scott Mendel and 40,000+ other insiders.